In the realm of pharmaceutical chemicals, certain compounds rise to prominence due to their significant impact on global health and their utility in cutting-edge research. Dihydroartemisinin (CAS 81496-82-4) is one such compound, highly valued as a pharmaceutical intermediate and a key component in antimalarial drug formulations. Its recognized therapeutic benefits, coupled with emerging research into its anticancer potential, make it a critical substance for the B2B market.

Dihydroartemisinin, typically presented as a white fine powder, is celebrated for its exceptional purity, often exceeding 99%. This high purity is essential for its application as an Active Pharmaceutical Ingredient (API) raw material, ensuring the efficacy and safety of the final medicinal products. The chemical formula C15H24O5 defines its structure, and its molecular weight of 284.35 g/mol are key parameters for formulators. Sourcing this compound requires engaging with suppliers who not only provide detailed specifications but also ensure consistent batch-to-batch quality, a hallmark of reliable manufacturers.

The primary and most well-documented application of Dihydroartemisinin is its role as a potent antimalarial agent. It is effective against various strains of the malaria parasite, including those resistant to traditional treatments. This efficacy makes it a cornerstone in many public health programs aimed at combating malaria worldwide. Furthermore, ongoing scientific exploration is uncovering its potential in cancer treatment, where it has shown promise in inducing cell death in certain malignant cells. This dual application profile underscores its importance for pharmaceutical companies and research institutions.

For organizations seeking to buy Dihydroartemisinin, identifying reliable manufacturers, particularly those based in China, is a strategic imperative. These suppliers often offer competitive Dihydroartemisinin prices due to scale and manufacturing efficiency. However, price should always be considered alongside quality assurances, such as GMP certification, ISO compliance, and the availability of thorough analytical documentation. A proactive approach to vetting suppliers and requesting samples for internal quality assessment is highly recommended.

The demand for high-quality Dihydroartemisinin powder is driven by its critical role in producing life-saving medications and its investigation in novel therapeutic areas. As a supplier, understanding these market needs and ensuring a stable, high-volume production capacity is key to serving the global pharmaceutical industry effectively. Whether for large-scale manufacturing or specialized research purposes, securing a dependable source of this vital intermediate is crucial for advancing healthcare solutions.

In conclusion, Dihydroartemisinin is a pivotal pharmaceutical intermediate with a significant impact on global health. Its established antimalarial properties and promising anticancer research make it a compound of high demand. We are committed to providing premium Dihydroartemisinin powder, meeting the rigorous standards required by the pharmaceutical industry. Contact us to discuss your procurement needs and to receive a competitive quote.